Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.

Academic Article


  • OBJECTIVE: To compare the relative safety and efficacy of Infasurf (calf lung surfactant extract; ONY, Inc, Amherst, NY, IND #27169) versus Survanta (Beractant, Ross Laboratories, Columbus, OH) in reducing the acute severity of respiratory distress syndrome (RDS) when given at birth and to infants with established RDS. DESIGN: A prospective, randomized, double-blind, multicenter clinical trial. SETTING: Thirteen neonatal intensive care units participated in the treatment arm: seven of these concurrently participated in the prevention arm. PATIENTS: The treatment arm enrolled infants of
  • Authors

    Published In

  • Pediatrics  Journal
  • Keywords

  • Age Factors, Apgar Score, Biological Products, Birth Weight, Double-Blind Method, Female, Gestational Age, Humans, Infant, Newborn, Infant, Small for Gestational Age, Male, Prospective Studies, Pulmonary Surfactants, Respiratory Distress Syndrome, Newborn
  • Author List

  • Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH
  • Start Page

  • 31
  • End Page

  • 38
  • Volume

  • 100
  • Issue

  • 1